Evaluation of the Pharmacokinetics, Safety and Tolerability of Single Dose of PF-06480605 in Chinese Healthy Participants

Clinical trial NCT05107492 · COMPLETED

Trial details

NCT number: NCT05107492
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammatory Bowel Disease

Start date: 2021-11-19
Primary completion: 2022-04-09
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.